Plus, news about Eledon, Sobi, Ovid and CytomX:
🗓️ Ionis updates prion disease study timelines: The California oligonucleotide powerhouse has pushed back the primary completion of its Phase 1/2a trial to February 2027, from an …
ACIP is being broken up. No it’s not. On Thursday afternoon, an outspoken member of the CDC’s Advisory Committee on Immunization Practices claimed that the
In San Francisco a few weeks ago, I caught up with Nworah Ayogu, partner at Thrive Capital. Thrive had recently announced that it raised a
The US FDA has approved a fourth product via its new National Priority Voucher Programme — a 7.2 mg dose of Novo Nordisk’s weight loss
The FDA approved a high-dose version of Novo Nordisk’s blockbuster weight loss injection Wegovy, giving its go-ahead about two months faster than normal thanks to
Verily has raised $300 million in new, outside funding that ends parent company Alphabet’s controlling position in the healthcare innovation company, Endpoints News has learned
Plus, news about Eledon, Sobi, Ovid and CytomX:
🗓️ Ionis updates prion disease study timelines: The California oligonucleotide powerhouse has pushed back the primary completion of its Phase 1/2a trial to February 2027, from an …